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Abstract: 
The aim of the study was to estimate the increasing capability of claudications distance 
in Fontaine's stage IIa of peripheral artery disease by influence of irregular 
acetylsalicylic acid (ASA) therapy and life style modification, combined with regular 
physical activity in diabetic and non-diabetic patients age over 55, in order to establish 
if there were any improvements in claudication distance in the both groups of patients. 
Method: This study was conducted from beginning of January, 2014 till end of January, 
2015 at the Clinic of Vascular Surgery, Clinical Center University of Sarajevo and 
included 60 patients age over 55 (30 patients who have diabetes mellitus and impellers 
group consisting of 30 patients who were clinically confirmed not to have diabetes 
mellitus), male and female, in stadium IIa of peripheral artery disease, with 
manifestation of mild claudication symptoms. For the testing of statistical significance 
of differences between the exanimated groups non-parameter and parameter tests were 
used. The difference at a level of p<0,05 was statistically significant. Results: In all the 
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tested patients, we investigated increasing of claudications distance in diabetic and non-
diabetic patients age over 55 years after one year study. Analysis shows the statistically 
significant influence of antiplatelet therapy (Acetylsalicylic acid) (ASA), combined with 
physical activity and life style modification on claudications distance over 500 meters in 
25 patients without diabetes mellitus in (83% p<0,05), compared to 12 patents with 
diabetes mellitus (40% p<0,05). Sixteen of non-diabetic patients (53%) were on 
antiplatelet therapy over 4 years, on permanent treatment, compared to 4 diabetic 
patients or (3%) (p<0,05). Conclusion: These clinical combined factors appeared to us as 
being the main strategy of the therapeutic effect on enhancement of claudication 
distance (Fontaine's stage II) of peripheral artery disease in patients with diabetes 
mellitus, as well as patients without it. 
 
Keywords: peripheral artery disease, claudication distance, diabetes mellitus, physical 
activity, life style modification  
 
1. Introduction  
 
Peripheral artery disease (PAD) is a progressive disease occurring as a result of plaque 
accumulation progress (claudication based on atherosclerosis pathologic process, 
mostly on low extremities) in the arterial system that carries insufficient oxygenated 
blood to the extremities as well as vital organs and it is not to be underestimate. 
Peripheral artery disease (PAD) may cause barrier or blockage of vessels in the legs and 
other parts of the body distant from the heart; pain occurs as the result of a reduction in 
the blood flow to the muscles of the legs (Abbott, Brand, & Kannel, 1990; Creager, 
Luscher, & Cosentino, 2003; Thomas, Lüscher, Mark, & Creager, 2003). The diagnosis of 
PAD is difficult because most patients remain asymptomatic for many years. The 
symptoms do not appear until there is at least 50% or more reduction and obstruction of 
healthy lumen of Superficial Femoral Artery and Popliteal Artery narrowing stenosis 
witch causing the claudication (Izquierdo-Porrera, Gardner, Bradham, et al. 2005; Steg, 
Bhatt, Wilson, D’Agostino, et al. 2007). In Fontaine’s stage IIa of peripheral artery 
disease the claudication symptomatology occurs in form of moderate and mild pain 
symptoms, caused by a distance greater than 200 meters. Certain conditions or habits 
may rise risk of peripheral artery disease (Thomas, Palumbo, Melton, et al. 2003; Belch, 
MacCuish, Campbell, et al. 2008). These conditions are known as risk factors. Before age 
55, women have a lower cardiovascular risk than men. Estrogen provides women with 
certain protection against cardiovascular disease before menopause. After age 55, 
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however, the risk of cardiovascular disease increases in both, women and men. 
Peripheral artery disease has been viewed as a disease of the lower extremities typified 
by claudication symptoms (Criqui, Denenberg, et al. 1998; AACPR, 2004; Golomb, 
Dang, & Criqui, 2006; Berger, Roncaglioni, Avanzini, et al. 2006). Patient with diabetes 
mellitus has a two- to four times shorter life expectancy, referring to complications 
caused by progression of cardiovascular disease. Diabetes and pre-diabetic stage highly 
increase the risk of cardiovascular disease progression, more in female than in male. 
(Arfvidsson, Wennmalm, Gelin, et al. 1992; Colwell, 1997; Ogawa, Nakayama, 
Morimoto, et al. 2008). The mechanism of elevation incidence in cardiovascular disease 
remains not entirely understood. In fact, having diabetes mellitus doubles a woman's 
risk of developing cardiovascular disease (Larsen, & Lasen, 1966; Hayden, Pignone, & 
Phillips, 2002). Patients with a history of peripheral artery disease have the same 
relative risk of cardiovascular death as patients with coronary or cerebrovascular 
disease (Thomas, Elliott, Naughton, 2009; Larose, Sigal, Khandwala, et al. 2012). 
 Peripheral artery disease is a result of  atherosclerotic disease progression, and it 
is not surprising  that patients with peripheral artery disease are higher exposed  to 
myocardial infarction, stroke, and all-cause mortality risk (Snowling, Hopkins, 2006; 
Gordon, Benson, Bird, et al. 2009; Colberg, Sigal, Fernhall, et al. 2010). The evidence 
proved that lifestyle modification with dietary modification and smoking cessation, 
combined with regular physical activity has an independent cardio-protective effect 
which may reduce overall cardiovascular risk. Using  acetylsalicylic acid therapy (75-
162 mg/d per day) in men age 45-79 years and women age 55-79 years, with or without 
diabetes, is a primary prevention strategy in patients having increased cardiovascular 
risk, including those who have additional risk factors (positive family history of 
cardiovascular disease, hypertension, smoking, dyslipidemia, or albuminuria) (Cai, 
Qiu, Ju, & Sun, 2014). The main mechanism of acetylsalicylic acid (ASA) is to block 
thromboxane synthesis by acetylating platelet cyclooxygenase. This therapy has been 
used as a primary and secondary strategy to prevent cardiovascular problems in non-
diabetic and diabetic patients. Multiple studies and large-scale collaborative trials in 
diabetic and non-diabetic patients, both male and female, confirmed that low-dose 
Acetylsalicylic acid (ASA) therapy should be prescribed as a secondary prevention 
strategy (Sigal, Kenny, Boulé, et al. 2007; Brun, Bordenave, Mercier, et al. 2008; Karstoft, 
Winding, Knudsen, et al. 2013). The recognition that physical activity with life style 
modification and low-dose of acetylsalicylic acid (ASA) 150 mg/ per day can increase 
the symptoms reduction in stadium IIa of peripheral artery disease and reduce 
progression of cardiovascular problems, caused the therapy became the most ideal 
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treatment in diabetic and non-diabetic patients, age over 55, with mild or moderate 
claudication symptoms (AACPR, 2004; Ogawa, Nakayama, Morimoto, et al. 2008). This 
strategy is a trend toward increasing risk reductions in diabetic and non-diabetic 
patients, allowing significant increases in walking distance and improving quality of 
life in general. Physical activity magnified blood flow through this collateral circuitry in 
animal models of peripheral artery disease. Improvements in collateral-dependent 
blood flow to hind limb muscles that occur with regular physical activity come to 
remolding and enlargement of collateral vessels and alternative blood routes. The 
capability of  physical activity combined with irregular acetylsalicylic acid (ASA)  
therapy and life style modification to alter the reactivity of collateral vessels has 
remained relatively unexplored (Jennings, Alberga, Sigal, et al. 2009; Plotnikoff, Eves, 
Jung, et al. 2010). 
 The aim of the study was to estimate the increasing capability of mild 
claudication distance in Fontaine's stage IIa of peripheral artery disease by influence of 
irregular acetylsalicylic acid (ASA) therapy and life style modification with regular 
physical activity in diabetic patients, without diabetic neuropathy and non-diabetic 
patients, after one year study at the Clinic of vascular surgery Clinical Center 
University of Sarajevo. 
 
 
Picture 1: Digital subtraction angiography (DSA) medical report shows multiple  
femoro-popliteal lesions significant hemodynamic obstructions of femoral and popliteal artery 
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2. Method 
 
The research was executed as a case retrospective study, which included the period of 
validity of one year; during it, the group of patients in stadium IIa of peripheral artery 
disease with or without diabetes mellitus was observed. This study was conducted at 
the Clinic of vascular surgery, Clinical Center University of Sarajevo and included 60 
patients of both genders, age over 55, with verified Femoro-Popliteal Stenosis over 50%, 
with or without diabetes mellitus, being in Fontaine’s stage IIa of peripheral artery 
disease, with manifestations of mild claudication symptoms, who met the criteria for 
being included in the study. Interval training program was composed as described: 
walking of 30-60 minutes, with repetitions of 100-200m, middle intensity, fast walking 
with a recovery period following each repetition, also with self-control heart frequency 
120-155 beats/min at max. intensity of 60 to 70% of heart rate, during at least one year, 
4-6 times a week. This study was conducted at the Clinic for vascular surgery, Centre of 
Sarajevo University and included 60 patients, male and female, with diabetes mellitus 
and without diabetes mellitus, which met the criteria for including in the study. Patients 
were divided into two groups; the first group consisted of 30 diabetic patients with non-
insulin resist. The first group consisted of 30 patients, who have diabetes mellitus; 
impellers group consists of 30 patients, clinically confirmed not to have diabetes 
mellitus. During period of one year research in non-diabetic and diabetic patients, 
progress of underlying disease was not confirmed; diabetic neuropathy and the 
presence of absence of lower limb and foot sensibility also, were not clinically 
confirmed during the study period. During one year training program procedure all 
diabetic patients were required to contact vascular surgeon and his medical team if 
health conditions become progressively worse (ulcus throphoneuroticum/traumaticum, 
other signs of foot ulceration, cold foot ischemia in progress, absence of sensibility, 
cancer, heart-attack, angina pectoralis, insulin therapy modification, etc.). Diabetic 
patients should also consume more complex carbohydrates, oligo and polysaccharides 
in form of cereals, combined with glass of orange juice and certain quantity of still 
water, at least one hour before working out. Main influence and attention of study is 
dedicated to diabetic patients because of complications of underlying disease.  
 All the patients, in spite of basic recommendation concerning combined 
treatment benefits (invasive or minimal-invasive reconstruction of PTA/stent/bypass) 
denied and refuse surgical treatment and have chosen conservative method of curing. 
The antiplatelet therapy in patients (diabetic and non-diabetic) was also changed (150 
mg of acetylsalicylic acid (ASA) per day/75 mg each 12 hours during one year, 
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compared with 100 mg of acetylsalicylic acid (ASA) a day, before research started. At 
the research beginning, all the patients were also physically examined by a medical 
team, led by vascular surgeon and his medical team, as well as at the end of the 
research. The study was approved by an institutional review board and all patients 








Total Patients who suffer from 
diabetes mellitus 





N 23 25 48 
% 76,7 83,3 80,0 
Female 
N 7 5 12 
% 23,3 16,7 20,0 
Total 
N 30 30 60 
% 50,0 50,0 100,0 
         
Table 2: The period of Acetylsalicylic acid (ASA) therapy in diabetic and  
non-diabetic patients age over 55 years 
 
 
Dose of Acetylsalicylic acid (ASA) 
150 mg/  per day 
Group 
Total Patients who suffer 
from diabetes mellitus 
Patients who didn’t suffer 
from diabetes mellitus 
 
1 year of using Acetylsalicylic 
acid (ASA) therapy 
N 2 13 15 
% 6,7 43,3 25,0 
6 mounths of using 
Acetylsalicylic acid (ASA) 
therapy 
N 3 5 8 
% 10,0 16,7 13,3 
2 years of using Acetylsalicylic 
acid (ASA) therapy 
N 4 3 7 
% 13,3 10,0 11,7 
3 years of using Acetylsalicylic 
acid (ASA)  therapy 
N 5 5 10 
% 16,7 16,7 16,7 
4 years of using Acetylsalicylic 
acid (ASA) therapy 
N 16 4 20 
% 53,3 13,3 33,3 
Total 
N 30 30 60 
% 50,0 50,0 100,0 
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Table 3: Estimation of claudication distance in diabetic and  
non-diabetic patients age over 55 years 
Claudications distance with mild claudication symptoms in meters 
Claudications distance in 
meters 
Group 
Total Patients who suffer from 
diabetes mellitus 




N 3 2 5 
% 10,0 6,7 8,3 
500m 
N 4 3 7 
% 13,3 10,0 11,7 
600m 
N 9 4 13 
% 30,0 13,3 21,7 
700m 
N 7 10 17 
% 23,3 33,3 28,3 
800m 
N 5 5 10 
% 16,7 16,7 16,7 
900m 
N 2 5 7 
% 6,7 16,7 11,7 
1000m 
N 0 1 1 
% ,0 3,3 1,7 
Total 
N 30 30 60 
% 50,0 50,0 100,0 
  
Table 4: Presence of a claudication distance with non-clinical symptoms of  




Total Patients who didn’t suffer from  
diabetes mellitus 




N 25 12 38 
% 83,3 40,0 46,7 
No 
N 5 18 23 
% 16,7 60,0 53,3 
Total 
N 30 30 60 
% 50,0 50,0 100,0 
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Table 5: Increasing of claudication distance in diabetic and non-diabetic patients   




Total Patients who did not suffer from  
diabetes mellitus 




N 30 30 60 
% 100 100 100 
No 
N 0 0 0 
% 0 0 0 
Total 
N 30 30 60 
% 50,0 50,0 100,0 
 
In our analysis we documented statistically significant difference in higher incidence 
between patients using acetylsalicylic acid, compared with period before using ASA;  in 
16 (53%) patients with diabetes mellitus in over 4 years period (p<0.05). The 13 non-
diabetic patient (43,3%) were statistically treated with acetylsalicylic acid in one  year 
period (p<0.05). Separate analysis was done in males and females, patients with or 
without diabetes mellitus. Comparison of main values by gender shows that there were 
more males represented  in the group of diabetics (76,7%) and non-diabetics, (83,3%) 
within no statistically significant differences within those groups (p>0.05). In this 
research we also documented the evaluation of claudication distance in diabetic 
patients and non-diabetic patients, which leads to conclusion that 10 (33,3%) of diabetic 
patients have reported claudication distance over 700m, compared to 9 (30%) non-
diabetic patient, which have reported claudication distance over 600m, with no 
statistically significant differences in the groups (p>0.05). Only 3 (3,3%) non-diabetic 
patients documented the claudication distance over 1000m (p>0.05). The lower 
claudications distance of 400m was reported in 2 diabetic patients (6,7%) and 3 non-
diabetic patients (10%).               
   
4. Discussion 
 
The study was based on data from history of disease and questionnaire carried out in 
all patients. During this study we have concluded that patients age over 55, who 
suffered from diabetes mellitus as a main unpredictable risk factor (Fontaine's stage IIa)  
of  peripheral artery disease also suffer from collateral circulation  deficiency, as a result 
of significant arterial destruction. Diabetes mellitus as accompanied disease of 
peripheral artery disease may increase disorders, which affects, either directly or 
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indirectly the functions of the arterial and collateral arterial system. The differences in 
effect of acetylsalicylic acid therapy between diabetic patient’s age over 55 without 
diabetic neuropathy and non-diabetic patient’s age over 55 were detected. As a 
summary review we have verified with continuous monitoring  the  statistical 
significant  presence of a claudication distance with non-clinical or subjective symptoms 
of peripheral artery disease after one year of study in our data analysis in (83,3%) or  25 
non-diabetic patients (p<0,05). We have proved the importance of connection between 
diabetes and a progression of peripheral artery disease, so that those patients should be 
more adequately treated by remolding the actual therapy. Enlargement of the collateral 
vessels (alternative blood routes) in diabetic patients is a main problem of underlying 
disease. Available evidence shows, however, that appropriate antiplatelet therapy in 
form of acetylsalicylic acid, physical activity and life style modification tends to increase 
the claudication distance  and  with  mild symptomatic pain  in Fontaine's stage IIa of  
peripheral artery disease statistically only in case of non-diabetic patients. Strategies for 
the body is to adapt and modified alternative blood circulation system by development 
of smaller peripheral arteries that will provide many pathways of blood flow around 
the ischemic area. This indicates that patients with mild claudicaton symptoms in 
Fontaine's stage IIa, in order to follow this strategic concept should be able to increase 
the claudication distance and return symptomatic stage of peripheral artery disease in 
asymptomatic stage of peripheral artery disease.  
 Patients with diabetes have potentially high level of arterial system destruction, 
increasing directly the cardiovascular risk and accelerating rapidly the development of 
peripheral artery disease. Adequate, regular, and timely therapy may prevent or delay 
these diabetic complications. Patient should be aware of the important relationship 
between diabetes and atherosclerosis and be prepared to be appropriately medically 
treated to reduce disability and avoid arterial diabetic complications. In study by 
Edward P Weiss and co. „Effects of matched weight loss from calorie restriction, exercise, or 
both on cardiovascular disease risk factors“: Reductions in body weight have substantial 
beneficial effects on cardiovascular (CVD) risk factors, so that with certainty we have 
proved that Interval Training Exercise Program and Life Style Modification (with sugar 
intake restriction, and reducing animal fat nutrition source) is vascular-protective 
modifying the alternative blood circulation with increasing the pain tolerance and 
returning to asymptomatic stage of peripheral artery disease (Weiss, Albert, Reeds et al. 
2016). Also the study by Byrne, Caulfield., & De Vito, 2015 “Effects of Self-directed 
Exercise Programmes on Individuals with Type 2 Diabetes Mellitus“ indicated that self-
directed exercise was found to be beneficial for diabetic individuals  for improving 
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glycosylated hemoglobin, physical characteristics, cardiorespiratory fitness, functional 
measures and other metabolic outcomes. Physical activity with life style modification 
and appropriate antiplatelet therapy in form of acetylsalicylic acid 150mg/d  (75 mg 
every 12 hours) should be implemented in  diabetic and non-diabetic patients  and 
unless it is contraindicated  by risk of gastrointestinal bleeding (gastric mucosal injury 
and gastrointestinal hemorrhage) or using alternative solution (clopidogrel 75mg/d). 
The role of physical exercise and training in the management of diabetes mellitus is 
more than recommended. This strategy would be helpful in the management of patients 
which were also connected with cardiovascular risk, depending on use of other 
effective techniques for cardiovascular risk reduction, including statins if necessary, 
blood pressure control, and smoking cessation. These combined therapies could be 
good alternative, in order to avoid unnecessary surgical treatment. The diabetic patients 
have to take special attention to their life style, having more discipline then non-diabetic 
patients. Working out is very important for establishment of collateral alternative blood 
vessel system, independently of taking aspirin. Of course, continuous taking of ASA 
would, maybe, has better effect on clinic benefits for atherosclerosis in diabetic and non-
diabetic patients, as well as long-lasting taking; further research is necessary for 
confirming this statement. Atherosclerosis as a form of stadium IIa of peripheral artery 
disease is significantly reduced by increasing the claudication distance over 500m after 
one year of study in diabetic and non-diabetic patients, using this combined therapy. 
Strategies for collateral re-vascularization must have been taken into consideration as 




Interval exercise training strategy and appropriate antiplatelet therapy should been 
incorporated into current guidelines for the management of peripheral artery disease in 
Fontaine's Stage II in patients who denied and  refuse surgical treatment because of its 
potential health benefits, in order to avoid certain or potential invasive or minimal 




1. Abbott RD, Brand FN, Kannel WB. (1990). Epidemiology of some peripheral arterial 
findings in diabetic men and women: experiences from the Framingham Study. Am J 
Med. (88),376-381. 
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović 
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING 
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC 
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
 
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017                                                  29 
2. Arfvidsson B, Wennmalm A, Gelin J, Dahllof AG, Hallgren B,Lundholm K. (1992). 
Co-variation between walking ability and circulatory alterations in patients with 
intermittent claudication. Eur J Vasc Surg. (6), 642- 646. 
3. American Association of Cardiovascular and Pulmonary Rehabilitation-AACPR. 
(2004). Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. 
Champaign, IL: Human Kinetics. 
4. Byrne, H., Caulfield, B. & De Vito, G. (2015). Effects of Self-directed Exercise 
Programmes on Individuals with Type 2 Diabetes Mellitus: A Systematic Review 
Evaluating Their Effect on HbA1c and Other Metabolic Outcomes. Physical 
Characteristics, Cardiorespiratory Fitness and Functional Outcomes Sports Med.(26), 1007-
1010. 
5. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. (2006). 
Aspirin for the primary prevention of cardiovascular events in women and men: a 
sex-specific meta-analysis of randomized controlled trials. JAMA (295), 306-13. 
6. Brun J, Bordenave S, Mercier J, et al. (2008). Cost-sparing effect of twice-weekly 
targeted endurance training in type 2 diabetics: a one-year controlled randomized 
trial. Diabetes Metab. 34 (3), 258-265. 
7. Criqui MH, Denenberg JO and al. (1998). The generalized nature of 
atherosclerosis:how peripheral arterial disease may predict adverse events from 
coronary artery disease. Vasc. Med. (3), 241-245. 
8. Creager MA, Luscher TF, Cosentino F, et al. (2003). Diabetes and vascular disease: 
pathophysiology, clinical consequences, and medical therapy: part I.Circulation. 
(108),1527–1532. 
9. Cobbe S, Taylor R, Prescott R, Lee R,Bancroft J, MacEwan S, Shepherd J, Macfarlane 
P, Morris A, Jung R,Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese 
G,McKnight J, O’Brien I, Semple C, Petrie J, Gordon D, Pringle S, Mac Walter R. 
(2008). The prevention of progression of arterial disease and diabetes (POPADAD) 
trial: factorial randomised placebo controlled trial of aspirin and antioxidants in 
patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:1840.  
10. Colwell JA (1997). Aspirin therapy in diabetes (Technical Review). Diabetes Care 
(20),1767–1771. 
11. Colberg S, Sigal R, Fernhall B, et al. (2010). Exercise and type 2 diabetes: the 
American College of Sports Medicine and the American Diabetes Association: joint 
position statement executive summary. Diabetes Care. 33(12), 2692–2696. 
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović 
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING 
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC 
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
 
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017                                                  30 
12. Cai X, Qiu S, Ju C, Sun Z. (2014). Pedometer-based walking intervention and resting 
blood pressure in type 2 diabetes: a meta-analysis of randomised controlled studies. 
Diabetologia (57),434. 
13. Golomb BA, Dang TT, Criqui MH. (2006). Peripheral arterial disease: morbidity and 
mortality implications. Circulation (114), 688 –699.  
14. Gordon B, Benson A, Bird S, et al. (2009). Resistance training improves metabolic 
health in type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 83 (2),157–175. 
15. Hayden M, Pignone M, Phillips C. (2002). Aspirin for the primary prevention of 
cardiovascular events: a summary of the evidence for the U.S. Preventive Services 
Task Force. Ann Intern Med (136),161–171. 
16. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, 
Powell CC, Katzel LI. (2005). Relationship between objective measures of peripheral 
arterial disease severity to self-reported quality of life in older adults with 
intermittent claudication. J Vasc Surg. (41), 625– 630. 
17. Jennings AE, Alberga A, Sigal RJ, et al. (2009). The effect of exercise training on 
resting metabolic rate in type 2 diabetes mellitus. Med Sci Sports Exerc. 41(8),1558–
1565. 
18. Karstoft K, Winding K, Knudsen SH, et al. (2013). The effects of free-living interval-
walking training on glycemic control, body composition, and physical fitness in type 
2 diabetic patients: a randomized, controlled trial. Diabetes Care. 36 (2),228–236. 
19. Larsen, O.A., and Lassen, NA. (1966). Effect of daily muscular exercise in patients 
with intermittent claudication. Lancet (2), 1093-1096. 
20. Larose J, Sigal R, Khandwala F, et al. (2012). Comparison of strength development 
with resistance training and combined exercise training in type 2 diabetes. Scand J 
Med Sci Sports. 22(4),45–54. 
21. Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N,Jinnouchi H, 
Sugiyama S, Saito Y. (2008). Japanese Primary Prevention of Atherosclerosis With 
Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary 
prevention of atherosclerotic events in patients with type 2 diabetes: a randomized 
controlled trial. JAMA (3)2134 – 2141. 
22. Plotnikoff R, Eves N, Jung M, et al. (2010). Multicomponent, home-based resistance 
training for obese adults with type 2 diabetes: a randomized controlled trial. Int J 
Obes. 34(12), 1733–1741. 
23. Snowling NJ, Hopkins WG. (2006). Effects of different modes of exercise training on 
glucose control and risk factors for complications in type 2 diabetic patients: a meta-
analysis. Diabetes Care. 29(11),2518–2527. 
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović 
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING 
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC 
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
 
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017                                                  31 
24. Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Rother J, Liau CS, 
Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. (2007). One-year cardiovascular 
event rates in outpatients with atherothrombosis. JAMA (297), 1197–1206. 
25. Sigal RJ, Kenny GP, Boulé NG, et al. (2007). Effects of aerobic training, resistance 
training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann 
Intern Med. 147(6), 357–369. 
26. Thomas RJ, Palumbo PJ, Melton LJ 3rd, et al. (2003). Trends in the mortality burden 
associated with diabetes mellitus: a population-based study in Rochester, Minn, 
1970 –1994. Arch Intern Med. (163),445– 451. 
27. Thomas F. Lüscher, MD, Mark A. Creager, MD (2003). Diabetes and Vascular 
Disease Pathophysiology, Clinical Consequences, and Medical Therapy: Part II. 
Circulation (108), 1655-1661. 
28. Thomas D, Elliott EJ, Naughton GA. (2009). Exercise for type 2 diabetes mellitus. 
Cochrane Database Syst Rev. (3), 2968. 
29. Weiss, EP., Albert,SG., Reeds,DN; Kress,KS; McDaniel, JL., Klein,S and Villareal, DT. 
(2016). Effects of matched weight loss from calorie restriction, exercise, or both on 


































Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović 
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING 
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC 
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
 





























































Creative Commons licensing terms 
Authors will retain the copyright of their published articles agreeing that a Creative Commons Attribution 4.0 International License (CC BY 4.0) terms 
will be applied to their work. Under the terms of this license, no permission is required from the author(s) or publisher for members of the community 
to copy, distribute, transmit or adapt the article content, providing a proper, prominent and unambiguous attribution to the authors in a manner that 
makes clear that the materials are being reused under permission of a Creative Commons License. Views, opinions and conclusions expressed in this 
research article are views, opinions and conclusions of the author(s). Open Access Publishing Group and European Journal of Physical Education and 
Sport Science shall not be responsible or answerable for any loss, damage or liability caused in relation to/arising out of conflict of interests, copyright 
violations and inappropriate or inaccurate use of any kind content related or integrated on the research work. All the published works are meeting the 
Open Access Publishing requirements and can be freely accessed, shared, modified, distributed and used in educational, commercial and non-
commercial purposes under a Creative Commons Attribution 4.0 International License (CC BY 4.0). 
